Connable Office Inc. Has $4.27 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Connable Office Inc. reduced its holdings in UnitedHealth Group by 15.1%, owning approximately $4.27 million worth of shares, making it their 29th largest position.
• Other institutions, such as GAMMA Investing LLC and UBS AM, significantly increased their stakes in UnitedHealth Group, reflecting strong institutional interest, with 87.86% of shares owned by institutions and hedge funds.
• UnitedHealth Group recently declared a quarterly dividend increase from $2.10 to $2.21, representing a yield of 3.7%, and its latest earnings report showed earnings per share of $4.08, missing the expected $4.45.

Connable Office Inc. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 15.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,156 shares of the healthcare conglomerate's stock after selling 1,447 shares during the period. UnitedHealth Group makes up approximately 0.5% of Connable Office Inc.'s holdings, making the stock its 29th biggest position. Connable Office Inc.'s holdings in UnitedHealth Group were worth $4,272,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC increased its stake in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after acquiring an additional 8,280,404 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after acquiring an additional 2,301,010 shares during the period. Northern Trust Corp increased its stake in UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after acquiring an additional 1,058,488 shares during the period. Capital International Investors raised its holdings in shares of UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after buying an additional 906,365 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in UnitedHealth Group in the fourth quarter valued at $367,521,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of the firm's stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director directly owned 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the firm's stock in a transaction dated Friday, May 16th. The shares were bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer owned 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Down 4.9%

Shares of NYSE:UNH opened at $237.40 on Monday. The company has a fifty day moving average of $296.86 and a 200-day moving average of $414.69. The company has a market capitalization of $215.36 billion, a PE ratio of 10.29, a price-to-earnings-growth ratio of 1.50 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.80 earnings per share. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 3.7%. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent research reports. Royal Bank Of Canada decreased their price objective on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Wolfe Research decreased their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. KeyCorp decreased their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Wells Fargo & Company cut their price target on UnitedHealth Group from $351.00 to $306.00 and set an "overweight" rating on the stock in a research note on Friday, July 25th. Finally, TD Securities reissued a "hold" rating and issued a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has an average rating of "Hold" and a consensus price target of $373.52.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.